Hepatocellular carcinoma (HCC) is the fifth most frequent cancer and the third cause of
cancer‐related mortality worldwide. The primary risk factor for HCC is liver cirrhosis …

Hepatocellular carcinoma (HCC) is the main type of primary liver malignancy and the fourth
leading cause of cancer-related death worldwide. MicroRNAs (miRNAs), a type of non …

Abstract Objectives Long non‐coding RNAs (lncRNAs) are emerging RNA regulators in
cancer progression, including in hepatocellular carcinoma (HCC). Recently, insufficient …

MAVS is essential for antiviral immunity, but the molecular mechanisms responsible for its
tight regulation remain poorly understood. Here, we show that NLK inhibits the antiviral …

Results: Researchers have reported that miRNAs can repress the expression of important
cancer-related genes and might be helpful in the diagnosis and treatment of cancer. During …

Liver cancer is the fourth leading cause of cancer related mortality in the world, with
hepatocellular carcinoma (HCC) representing the most common primary subtype. Two …

Antihyperglycemic therapy is an important priority for the treatment of type 2 diabetes (T2D).
Excessive hepatic glucose production (HGP) is a major cause of fasting hyperglycemia …

Nemo-like kinase (NLK) is an evolutionarily conserved MAP kinase-related kinase. Although
NLK was originally identified as a Drosophila gene affecting cell movement during eye …

Abstract Nemo-like kinase (NLK), an evolutionarily conserved MAP kinase-related kinase,
has been reported to be involved in the development of hepatocellular carcinoma (HCC) …

Objective In this study, we explored the use of mechanical high intensity focused ultrasound
(M-HIFU) as a neo-adjuvant therapy prior to surgical resection of the primary tumor. We also …